Sigal DS - Search Results

1

An observational study of hospitalized COVID-19 patients with cancer in San Diego county.

Hermel DJ, Cham J, Spierling Bagsic SR, Hong LK, Costantini CL, Mason JR, Saven A, Sigal DS. Hermel DJ, et al. Among authors: sigal ds. Future Oncol. 2022 Feb;18(6):719-725. doi: 10.2217/fon-2021-1116. Epub 2022 Feb 2. Future Oncol. 2022. PMID: 35105156 Free PMC article.

2

Cladribine in indolent non-Hodgkin's lymphoma.

Sigal DS, Saven A. Sigal DS, et al. Expert Rev Anticancer Ther. 2008 Apr;8(4):535-45. doi: 10.1586/14737140.8.4.535. Expert Rev Anticancer Ther. 2008. PMID: 18402520 Review.

3

Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.

Huynh E, Sigal D, Saven A. Huynh E, et al. Leuk Lymphoma. 2009 Oct;50 Suppl 1:12-7. doi: 10.3109/10428190903142083. Leuk Lymphoma. 2009. PMID: 19814692 Review.

4

Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine.

Sigal DS, Sharpe R, Burian C, Saven A. Sigal DS, et al. Blood. 2010 Mar 11;115(10):1893-6. doi: 10.1182/blood-2009-10-251645. Epub 2010 Jan 7. Blood. 2010. PMID: 20056789 Free article.

5

In vivo targeting of B-cell lymphoma with glycan ligands of CD22.

Chen WC, Completo GC, Sigal DS, Crocker PR, Saven A, Paulson JC. Chen WC, et al. Among authors: sigal ds. Blood. 2010 Jun 10;115(23):4778-86. doi: 10.1182/blood-2009-12-257386. Epub 2010 Feb 24. Blood. 2010. PMID: 20181615 Free PMC article.

6

Beyond hairy cell: the activity of cladribine in other hematologic malignancies.

Sigal DS, Miller HJ, Schram ED, Saven A. Sigal DS, et al. Blood. 2010 Oct 21;116(16):2884-96. doi: 10.1182/blood-2010-02-246140. Epub 2010 Jul 15. Blood. 2010. PMID: 20634380 Free article. Review.

7

Hairy cell leukemia: current therapies and future directions.

Vosganian GS, Sigal DS, Saven A. Vosganian GS, et al. Among authors: sigal ds. Expert Rev Hematol. 2010 Dec;3(6):679-83. doi: 10.1586/ehm.10.67. Expert Rev Hematol. 2010. PMID: 21091144

8

Development of cladribine at Scripps for hairy cell leukemia and current results.

Torrey ML, Sigal DS, Saven A. Torrey ML, et al. Among authors: sigal ds. Leuk Lymphoma. 2011 Jun;52 Suppl 2:29-33. doi: 10.3109/10428194.2011.569621. Epub 2011 Apr 19. Leuk Lymphoma. 2011. PMID: 21504293 Review.

9

Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22.

Chen WC, Sigal DS, Saven A, Paulson JC. Chen WC, et al. Among authors: sigal ds. Leuk Lymphoma. 2012 Feb;53(2):208-10. doi: 10.3109/10428194.2011.604755. Epub 2011 Aug 24. Leuk Lymphoma. 2012. PMID: 21756025 Free PMC article. Review.

10

The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer.

Hermel DJ, Sigal D. Hermel DJ, et al. J Pers Med. 2019 Jan 16;9(1):5. doi: 10.3390/jpm9010005. J Pers Med. 2019. PMID: 30654522 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page